In this week’s edition of the BioLines Weekender we introduce a new section entitled “Economic Developments.” In addition to highlighting the numerous companies moving to the Garden State, we will be spotlighting those expanding their footprint, such as BioNJ Member Allergan.
This week, Allergan announced that its new U.S. Administrative Headquarters, expected to be completed in 2017 in Madison, N.J., will house the company’s New Jersey-based corporate, commercial, research & development and other shared services functions bringing together more than 1,000 employees with an expected additional 300 new hires.
Meanwhile, New Jersey was ranked #1 in Drug/Pharma Leaders and #2 in Biotech Leadership in the 2016 Business Facilities Rankings just released.
BioNJ will be bringing together life sciences thought leaders for our 4th Annual CEO Summit taking place on September 23. The convenient full-day program will deliver valuable perspectives from industry experts on how to navigate the dynamic landscape of bringing a product to market. The outstanding roster of key stakeholders at the forefront of this vital conversation include Mark J. Alles, CEO, Celgene Corporation; James Greenwood, President & CEO, BIO; Dr. Karin Hehenberger, Founder, Chairman & CEO, LYFEBULB; Jesper Høiland, Executive Vice President, U.S., Novo Nordisk; Dr. Stelios Papadopoulos, Chairman, Biogen; Linda Pissott Reig, Esq., Shareholder, Buchanan Ingersoll and Rooney; Dr. Susan Shiff, Senior Vice President & Head of the Center for Observational and Real World Evidence, Merck & Co. and Harry J. Travis, President & CEO, eTect, Inc., and Former Vice President, Aetna Specialty and Home Delivery Pharmacy — with additional speakers to be announced. Click here to register and learn about sponsorship opportunities.
Click here to read this week’s Weekender.